Six join Lundbeck’s Dkr2.5bn deal
Denmark’s Lundbeck, the pharmaceutical group, has signed a debut Dkr2.5bn ($450m) facility backing its $900m takeover of Ovation Pharmaceuticals, the US company, which was announced in February. Bookrunners Danske Bank and Nordea were joined by six banks during syndication.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
